EP1156816A4 - Peptides modulating activities of heparin, other glycosaminoglycans or proteoglycans - Google Patents

Peptides modulating activities of heparin, other glycosaminoglycans or proteoglycans

Info

Publication number
EP1156816A4
EP1156816A4 EP00905964A EP00905964A EP1156816A4 EP 1156816 A4 EP1156816 A4 EP 1156816A4 EP 00905964 A EP00905964 A EP 00905964A EP 00905964 A EP00905964 A EP 00905964A EP 1156816 A4 EP1156816 A4 EP 1156816A4
Authority
EP
European Patent Office
Prior art keywords
glycosaminoglycans
proteoglycans
heparin
modulating activities
peptides modulating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00905964A
Other languages
German (de)
French (fr)
Other versions
EP1156816A1 (en
Inventor
Antonio James D San
Angela Verrecchio
Barbara P Schick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thomas Jefferson University
Original Assignee
Thomas Jefferson University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomas Jefferson University filed Critical Thomas Jefferson University
Publication of EP1156816A1 publication Critical patent/EP1156816A1/en
Publication of EP1156816A4 publication Critical patent/EP1156816A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
EP00905964A 1999-02-02 2000-02-02 Peptides modulating activities of heparin, other glycosaminoglycans or proteoglycans Withdrawn EP1156816A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11827699P 1999-02-02 1999-02-02
US118276P 1999-02-02
PCT/US2000/002853 WO2000045831A1 (en) 1999-02-02 2000-02-02 Peptides modulating activities of heparin, other glycosaminoglycans or proteoglycans

Publications (2)

Publication Number Publication Date
EP1156816A1 EP1156816A1 (en) 2001-11-28
EP1156816A4 true EP1156816A4 (en) 2004-12-29

Family

ID=22377591

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00905964A Withdrawn EP1156816A4 (en) 1999-02-02 2000-02-02 Peptides modulating activities of heparin, other glycosaminoglycans or proteoglycans

Country Status (3)

Country Link
EP (1) EP1156816A4 (en)
CA (1) CA2361612A1 (en)
WO (1) WO2000045831A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8003595B2 (en) 2000-03-01 2011-08-23 Cellectis Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
EP1355675A1 (en) * 2001-01-30 2003-10-29 Universite Catholique De Louvain Anti-tumor compounds
US7049286B2 (en) 2001-08-30 2006-05-23 Diatos, S.A. Insulin conjugates and methods of use thereof
WO2003054146A2 (en) 2001-11-14 2003-07-03 Northwestern University Self-assembly and mineralization of peptide-amphiphile nanofibers
WO2003070749A2 (en) 2002-02-15 2003-08-28 Northwestern University Self-assembly of peptide-amphiphile nanofibers under physiological conditions
US7534761B1 (en) 2002-08-21 2009-05-19 North Western University Charged peptide-amphiphile solutions and self-assembled peptide nanofiber networks formed therefrom
US7554021B2 (en) 2002-11-12 2009-06-30 Northwestern University Composition and method for self-assembly and mineralization of peptide amphiphiles
AU2003298647A1 (en) 2002-11-14 2004-06-15 Claussen, Randal, C. Synthesis and self-assembly of abc triblock bola peptide
IL153762A0 (en) * 2002-12-31 2003-07-06 Rimonyx Pharmaceuticals Ltd Methods of screening for anti-inflammatory drugs and use thereof
US7259140B2 (en) 2003-03-28 2007-08-21 Thomas Jefferson University Heparin-binding peptides and uses thereof
BRPI0413521A (en) 2003-08-14 2006-10-10 Diatos amino acid sequences that facilitate the penetration of a substance of interest into cells and / or cell nuclei
WO2005056576A2 (en) 2003-12-05 2005-06-23 Northwestern University Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof
CN102225964A (en) 2003-12-05 2011-10-26 西北大学 Self-assembling peptide amphiphiles and related methods for growth factor delivery
KR20070108555A (en) * 2005-03-04 2007-11-12 노오쓰웨스턴 유니버시티 Angiogenic heparin binding peptide amphiphiles
EP1797901A1 (en) 2005-12-16 2007-06-20 Diatos Cell penetrating peptide conjugates for delivering nucleic acids into cells
EP1818395A1 (en) 2006-02-08 2007-08-15 Diatos Compositions and methods for treating lysosomal storage diseases
CA2658015A1 (en) 2006-03-30 2007-10-11 Diatos S.A. Camptothecin-peptide conjugates and pharmaceutical compositions containing the same
US8076295B2 (en) 2007-04-17 2011-12-13 Nanotope, Inc. Peptide amphiphiles having improved solubility and methods of using same
KR20120012811A (en) 2009-04-13 2012-02-10 노오쓰웨스턴 유니버시티 Novel peptide-based scaffolds for cartilage regeneration and methods for their use
ES2864864T3 (en) * 2013-02-12 2021-10-14 Headsight Inc Diagnostic system for a controller

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995013083A1 (en) * 1993-11-12 1995-05-18 University Of Michigan, The Board Of Regents Novel peptides for heparin and low molecular weight heparin anticoagulation reversal

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770563A (en) * 1991-12-06 1998-06-23 The United States Of America As Represented By The Department Of Health And Human Services Heparin- and sulfatide binding peptides from the type I repeats of human thrombospondin and conjugates thereof
US5877153A (en) * 1996-06-11 1999-03-02 Commonwealth Biotechnologies Inc. Heparin-binding peptides

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995013083A1 (en) * 1993-11-12 1995-05-18 University Of Michigan, The Board Of Regents Novel peptides for heparin and low molecular weight heparin anticoagulation reversal

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHILLEMI FRANCESCO ET AL: "Synthesis and cytotoxic activity of new peptides containing basic amino acid residues", ANTICANCER RESEARCH, vol. 18, no. 2A, March 1998 (1998-03-01), pages 757 - 758, XP009034295, ISSN: 0250-7005 *
See also references of WO0045831A1 *
VERRECCHIO ANGELA ET AL: "Design of peptides with high affinities for heparin and endothelial cell proteoglycans", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 275, no. 11, 17 March 2000 (2000-03-17), pages 7701 - 7707, XP002289447, ISSN: 0021-9258 *

Also Published As

Publication number Publication date
WO2000045831A1 (en) 2000-08-10
CA2361612A1 (en) 2000-08-10
EP1156816A1 (en) 2001-11-28

Similar Documents

Publication Publication Date Title
EP1156816A4 (en) Peptides modulating activities of heparin, other glycosaminoglycans or proteoglycans
GB2335747B (en) Signalling heart function
GC0000248A (en) Novel heterocyclic sulfonamides
ZA200003312B (en) Display units.
DE59800452D1 (en) STORAGE-RESISTANT, PERMANENTLY WATER-WETTABLE, VOLCANISATE-RESULTING POLYSILOXANIZE
HK1049886A1 (en) Multi-channel fiber-optic rotary joint.
AU5145900A (en) Design maturity algorithm
MXPA02004741A (en) Liquid heparin formulation.
GB9925469D0 (en) Seal assemblies
AU4359900A (en) Dome structure
AU1740601A (en) Conveyor track of the smart-track type
ZA99473B (en) New naphthyl- and anilide-substituted sulphonamides.
AU5995400A (en) Signalling system
IL133594A0 (en) High pressure spray system
IT1304358B1 (en) EQUILIBRATOR BODY EQUIPPED.
DE60042546D1 (en) TITANIUM COMPOSITE
ZA200006750B (en) Prosthesis System.
GB9917968D0 (en) Harvester undercarriage
GB9903804D0 (en) Pluripotential cells-2
GB0029720D0 (en) I.S machine7544232001
MXPA01011927A (en) Composite coating.
MXPA02001479A (en) Blood plasma replacement solution.
ZA200109120B (en) Use of Arylalkanoylpyridazines.
AU5724900A (en) Pseudomycin n-acyl side-chain analogs
GB9925541D0 (en) The flexi:bak

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010903

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20041108

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050127